Nutraceutical potential of soybean: Review

Asian Journal of Clinical Nutrition

Volumn 7, Issue 2, 2015, Pages 22-32

  Tidke, Shashank A ^b   Ramakrishna, D ^a   Kiran, S ^a   Kosturkova, G ^b   Ravishankar, G A ^a  

^a Dayananda Sagar College of Engineering   (India)

^b INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Essential amino acids; Folic acid; Glycine max; Health foods; Isoflavones; Nutraceutical; PUFA; Soybean

Indexed keywords

EID: 84944874464     PISSN: 19921470     EISSN: 20772033     Source Type: Journal    
DOI: 10.3923/ajcn.2015.22.32     Document Type: Article

References (52)

1. Anthony, M.S., T.B. Clarkson, C.L. Hughes, Jr., T.M. Morgan and G.L. Burke, 1996. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr., 126: 43-50.
2. Barua, S., S. Kuizon and M.A. Junaid, 2014. Folic acid supplementation in pregnancy and implications in health and disease. J. Biomed. Sci., Vol. 21.
3. Blencowe, H., S. Cousens, B. Modell and J. Lawn, 2010. Folic acid to reduce neonatal mortality from neural tube disorders. Int. J. Epidemiol., 39: 110-121.
4. Bondesson, M. and J.A. Gustafsson, 2010. Does consuming isoflavones reduce or increase breast cancer risk? Genome Med., Vol. 2.
5. Businco, L., G. Bruno, P.G. Giampietro and A. Cantani, 1992. Allergenicity and nutritional adequacy of soy protein formulas. J. Pediatr., 121: S21-S28.
6. Byun, J.S., Y.S. Han and S.S. Lee, 2010. The effects of yellow soybean, black soybean and sword bean on lipid levels and oxidative stress in ovariectomized rats. Int. J. Vitamin Nutr. Res., 80: 97-106.
7. Chen, W.F., M.H. Huang, C.H. Tzang, M. Yang and M.S. Wong, 2003. Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis., 1638: 187-196.
8. Devi, M.K.A., M. Gondi, G. Sakthivelu, P. Giridhar, T. Rajasekaran and G.A. Ravishankar, 2009. Functional attributes of soybean seeds and products, with reference to isoflavone content and antioxidant activity. Food Chem., 114: 771-776.
9. Dixit, A.K., J.I.X. Antony, N.K. Sharma and R.K. Tiwari, 2011. Soybean Constituents and their Functional Benefits. In: Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry, Tiwari, V.K. and B.B. Mishra (Eds.). Research Signpost, Trivandrum, India, ISBN-13: 9788130804484.
10. Djukic, A., 2007. Folate-responsive neurologic diseases. Pediatr. Neurol., 37: 387-397.
11. Erdman, J.W. Jr. and E.J. Fordyce, 1989. Soy products and the human diet. Am. J. Clin. Nutr., 49: 725-737.
12. Espinosa-Martos, I. and P. Ruperez, 2006. Soybean oligosaccharides: Potential as new ingredients in functional food. Nutr. Hosp., 21: 92-96.
13. Fekete, K., C. Berti, I. Cetin, M. Hermoso, B.V. Koletzko and T. Decsi, 2010. Perinatal folate supply: Relevance in health outcome parameters. Maternal Child Nutr., 6: 23-38.
14. Friedman, M. and D.L. Brandon, 2001. Nutritional and health benefits of soy proteins. J. Agric. Food Chem., 49: 1069-1086.
15. Gandhi, A.P., 2008. Development of HACCP procedure for the production of full fat soy flour. Int. Food Res. J., 15: 141-154.
16. Grieshop, C.M., C.T. Kadzere, G.M. Clapper, E.A. Flickinger, L.L. Bauer, R.L. Frazier and G.C. Fahey Jr., 2003. Chemical and nutritional characteristics of united states soybeans and soybean meals. Agric. Food Chem., 51: 7684-7691.
17. Hammond, B.G. and J.M. Jez, 2011. Impact of food processing on the safety assessment for proteins introduced into biotechnology-derived soybean and corn crops. Food Chem. Toxicol., 49: 711-721.
18. Hosking, R., 1996. A Dictionary of Japanese Food: Ingredients and Culture. Tuttle Publishing, Boston, MA., Pages: 239.
19. Hymowitz, T., 1970. On the domestication of the soybean. Econ. Bot., 23: 408-421.
20. Hymowitz, T. and C.A. Newell, 1981. Taxonomy of the genus Glycine, domestication and uses of soybeans. Econ. Bot., 35: 272-288.
21. Hymowitz, T. and R.J. Singh, 1987. Taxonomy and Speciation. In: Soybeans: Improvement, Production and Uses, Wilcox, J.R. (Ed.). 2nd Edn., CSSA and SSSA, Madison, ASA, WI, pp: 134-179.
22. Isanga, J. and G.N. Zhang, 2008. Soybean bioactive components and their implications to health-a review. Food Rev. Int., 24: 252-276.
23. Ito, C., T. Murata, M. Itoigawa, K. Nakao, M. Kumagai, N. Kaneda and H. Furukawa, 2006. Induction of apoptosis by isoflavonoids from the leaves of Millettia taiwaniana in human leukemia HL-60 cells. Planta Medica, 72: 424-429.
24. Kaufman, P.B., J.A. Duke, H. Brielmann, J. Boik and J.E. Hoyt, 1997. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: Implications for human nutrition and health. J. Alter. Complementary Med., 3: 7-12.
25. Kennedy, A.R., 1998. The bowman-birk inhibitor from soybeans as an anticarcinogenic agent. Am. J. Clin. Nutr., 68: 1406S-1412S.
26. Kim, H.A., K.S. Jeong and Y.K. Kim, 2008. Soy extract is more potent than genistein on tumor growth inhibition. Anticancer Res., 28: 2837-2841.
27. Kreijkamp-Kaspers, S., L. Kok, D.E. Grobbee, E.H. de Haan, A. Aleman, J.W. Lampe and Y.T. van der Schouw, 2004. Effect of soy protein containing isoflavones on cognitive function, bone mineral density and plasma lipids in postmenopausal women: A randomized controlled trial. J. Am. Med. Assoc., 292: 65-74.
28. Kudou, S., Y. Fleury, D. Welti, D. Magnolato, T. Uchida, K. Kitamura and K. Okubo, 1991. Malonyl isoflavone glycosides in soybean seeds (Glycine max Merrill). Agric. Biol. Chem., 55: 2227-2233.
29. Kushwaha, K., C.A. O'Bryan, D. Babu, P.G. Crandall, O. Chen and S.O. Lee, 2014. Human health effects of isoflavones from soybeans. Agric. Food Anal. Bacteriol., 4: 122-142.
30. Lersten, N.R. and J.B. Carlson, 1987. Vegetative Morphology. In: Soybeans: Improvement, Production and Uses, Wilcox, J.R. (Ed.). 2nd Edn., American Society of Agronomy, Madison, WI., pp: 49-94.
31. Li, Y., L. Liu, L.G. Andrews and T.O. Tollefsbol, 2009. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int. J. Cancer, 125: 286-296.
32. Liu, K.S., 1997. Chemistry and Nurtitional Value of Soybean Components. In: Soybeans: Chemistry, Technology and Utilization, Liu, K.S. (Ed.). Chapman and Hall, New York, USA., pp: 25-113.
33. McCloud, T., 1992. Natto: A Breakfast Dish that's an Acquired Taste. Daily Press, Virginia, USA.
34. Messina, M.J., 1997. Soybean Foods: Their Role in Disease Prevention and Treatment. In: Soybeans: Chemistry, Technology and Utilization, Liu, K.S. (Ed.). Chapman and Hall, New York, USA., pp: 442-447.
35. Messina, M. and B. Lane, 2007. Soy protein, soybean isoflavones and coronary heart disease risk: Where do we stand? Future Lipidol., 2: 55-74.
36. Messina, M., 2008. Investigating the optimal soy protein and isoflavone intakes for women: A perspective. Women's Health, 4: 337-356.
37. Michelfelder, A.J., 2009. Soy: A complete source of protein. Am. Fam. Physician, 79: 43-47.
38. Muller, U., W. Weber, A. Hoffmann, S. Franke, R. Lange and S. Vieths, 1998. Commercial soybean lecithins: A source of hidden allergens? Zeitschrift Lebensmitteluntersuchung Und-Forschung A, 207: 341-351.
39. Nagarajan, S., 2010. Mechanisms of anti-atherosclerotic functions of soy-based diets. J. Nutr. Biochem., 21: 255-260.
40. Persley, G.J., J.N. Siedow, M. Gasson and C.O. Qualset, 1999. Applications of biotechnology to crops: Benefits and risks. Council for Agricultural Science and Technology, Issue Paper 12, December 1999, pp: 1-8.
41. Sabudak, T. and N. Guler, 2009. Trifolium L.-a review on its phytochemical and pharmacological profile. Phytother. Res., 23: 439-446.
42. Sacks, F.M., A. Lichtenstein, L. van Horn, W. Harris, P. Kris-Etherton and M. Winston, 2006. Soy protein, isoflavones and cardiovascular health: An American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation, 113: 1034-1044.
43. Setchell, K.D., C. Clerici, E.D. Lephart, S.J. Cole and C. Heenan et al., 2005. S-equol, a potent ligand for estrogen receptor ß, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am. J. Clin. Nutr., 81: 1072-1079.
44. Sikorski, Z.E., 2007. Chemia Zywnosci. 5th Edn., Wnt, Sweden, ISBN-13: 978-8320432732, Pages: 244.
45. Singh, P., R. Kumar, S.N. Sabapathy and A.S. Bawa, 2008. Functional and edible uses of soy protein products. Compr. Rev. Food Sci. Food Saf., 7: 14-28.
46. Smith, K.L. and W. Huyser, 1987. World Distribution and Significance of Soybean. In: Soybeans: Improvement, Production and uses, Wilcox, J.R. (Ed.). 2nd Edn., American Society of Agronomy, Madison, WI., USA., pp: 1-22.
47. Sotoca, A.M., M.D.S. Gelpke, S. Boeren, A. Strom and J.A. Gustafsson et al., 2010. Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol. Cell. Proteom., Vol. 10. 10.1074/mcp.M110.002170
48. Sugano, M., 2006. Soy in Health and Disease Prevention. CRC Press, Boca Raton, FL., ISBN-13: 978-0849335952, Pages: 328.
49. Tavva, V.S., Y.H. Kim and I.A. Kagan, R.D. Dinkins, K.H. Kim and G.B. Collins, 2007. Increased α-tocopherol content in soybean seed overexpressing the Perilla frutescens γ-tocopherol methyltransferase gene. Plant Cell Rep., 26: 61-70.
50. Wiseman, H., 1999. The bioavailability of non-nutrient plant factors: dietary flavonoids and phytooestrogens. Proc. Nutr. Soc., 58: 139-146.
51. Wiseman, H., J.D. O'Reilly, H. Adlercreutz, A.I. Mallet, E.A. Bowey, I.R. Rowland and T.A.B. Sanders, 2000. Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr., 72: 395-400.
52. Xiao, C.W., 2008. Health effects of soy protein and isoflavones in humans. J. Nutr., 138: 1244S-1249S.